The story of how pharmaceutical firms buy doctors to prescribe given medication would be unbelievable if it appeared in some publication with less credibility than the Bulletin of the AARP.

Here’s the reported way in which a sales manager at Astra-Zeneca described the filthy operation: “There’s a big bucket of money sitting in every office. Every time you go in you reach your hand in the bucket and grab a handful.”

Little did the teller of this tale expect that his words would turn up on the Internet. But they did.

Forwarding the News

Thoughtful, balanced reporting from the Forward and around the web, bringing you updated news and analysis each day.

Terms(Required)

I agree to the Forward's Terms of Service and Privacy Policy

Email(Required)

But even if they did not, the truth about the way in which pharmaceutical firms seek to buy doctors to prescribe their product would have been brought to public attention. A two-year Senate Finance Committee probe has concluded that by funding continuing medical education programs for doctors, pharmaceutical companies “have been able to increase their market for new products” and to illegally promote “off label uses” for their drugs. The committee has expressed concern that persuading doctors to use more costly drugs raises safety issues and most certainly places an additional cost on government funding.

The New England Journal of Medicine reports that 94% of doctors have a relationship with drug companies, 83% get free meals and 35% attend industry events.

They used to call such acts “bribery.” Now, we guess it goes under another name — like friendship.

A message from our Publisher & CEO Rachel Fishman Feddersen

I hope you appreciated this article. Before you go, I’d like to ask you to please support the Forward’s award-winning, nonprofit journalism during this critical time.

The coming year promises to be filled with more complex and historic developments. We are entering an era where independent, fact-based Jewish journalism will be more important than ever. We need to be ready for whatever 2025 will bring, and with your help, we can be.

We’ve set a goal to raise $260,000 by December 31. That’s an ambitious goal, but one that will give us the resources we need to invest in the high quality news, opinion, analysis and cultural coverage that isn’t available anywhere else.

If you feel inspired to make an impact, now is the time to give something back. Join us as a member at your most generous level.

—  Rachel Fishman Feddersen, Publisher and CEO

With your support, we’ll be ready for whatever 2025 brings.

$36 $500

$120 $180 Other amount